Występowanie przeciwciał dla wybranych antygenów Pseudomonas aeruginosa u dzieci i młodych dorosłych chorych na mukowiscydozę
Introduction
Cystic fibrosis (CF) is a genetically determined, multiorgan, autosomal recessive disease. It cannot be cured (similarly as other genetic diseases), but knowledge about its pathogenesis, the course of the disease, early detection of complications and the improvement of treatment methods have significantly extended survival time and ameliorated its quality.
Cystic fibrosis develops due to mutation of the gene encoding the CFTR protein (cystic fibrosis transmembrane conductance regulator), which is found in the apical membrane of the surface of epithelial cells. The effect of inappropriate functioning of CFTR is dehydration and the condensation of secretion in excretory ducts of the exocrine glands. Excessive density of secretion causes disturbances in the transport through the excretory ducts, with its progressive damage. The epithelium of the airways is particularly exposed to the development of bacterial infections, whereas the impairment of ciliary clearance hinders the elimination of pathogens. At the initial stage of the disease, the airways are the most frequently infected with Haemophilus influenzae and Staphylococcus aureus. As the disease progresses, Pseudomonas aeruginosa infections develop. Over time, P.a. is the dominating pathogen with a negative influence on the respiratory system. At the beginning, non-mucoid, in vitro susceptible to antibiotics P. aeruginosa strains are usually cultured [1, 2] . Together with the progression of the disease, the frequency of isolation of the mucoid form of P. aeruginosa increases.
Eradication of P.a. in CF patients is possible if it is initiated early in the course of infection [2, 3] . Therefore, early detection of P.a. is an important target in monitoring CF patients. The application of serological methods may be useful in early detection of infection [4, 5] .
The objective of the study was to evaluate the concentration of antibodies to selected antigens of P.a. (alkaline protease, elastase and exotoxin A) in serum of cystic fibrosis patients with known history of infection, and to compare the obtained results with microbiological tests.
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Material and methods
The analysis included 111 CF patients diagnosed and treated at the Institute of Tuberculosis and Lung Diseases in Rabka Zdrój. Depending on the results of the previous sputum or swab cultures for P. aeruginosa taken at least every 3 months during the previous 12 months, patients were divided into three groups, according to the definition by Lee et al. [6] Material from the airways (sputum collected from older children and adults, or swabs from the throat of younger children) were analysed according to the manufacturer's guidelines. In patients with exacerbations, material was taken prior to the start of antibiotic therapy. In patients treated with inhaled antibiotics, material was taken at least 12 hours after the last dose. Media produced by the company Graso were used. The cultured P. aeruginosa strains were identified with the help of ID 32 GN strips, BioMerieux Polska, using miniAPI apparatus.
Results
The mean age of patients with CF was 11.2 ± 6.0 years, range from 3 months to 28.1 years.
The mean age in the study groups was as follows: Table 1 shows the relationship between the current results of P. a. culture and the data concerning the type of infection. The frequency of currently positive cultures of P. a. and its mucoid morphotype increased together with the infection chronicity. Among patients with intermittent infection (Group 2), the growth of P. a. was found in 9/29 patients (31%), including the growth of mucoid strain in 2 patients (7%), non-mucoid in 6 patients (21%) and both types in 1 patient (3%). Among patients with chronic infection (Group 3), the growth of P.a. was found in 48/55 patients (87%), including the growth of mucoid strain in 15 patients (27%), non--mucoid in 13 patients (24%) and both types in 20 patients (36%).
In 60 patients, elevated concentration of IgG antibodies was found (> 500 U) for at least one P. aeruginosa antigen, and in 30 patients -for all examined antigens. Positive results were obtained in 40 patients (36%) for alkaline protease (AP), in 46 patients (41%) for elastase (ELA), and in 47 patients (42%) for exotoxin A (Exo-A). For AP antigen, the frequency of elevated antibody concentration was 14% among intermittently infected patients (Group 2) and 62% among chronically infected patients (Group 3). Similar dependencies were found for the remaining antigens: for ELA -17% and 71% in Groups 2 and 3, respectively, and for Exo-A -24% and 65%, respectively (Table 2) .
Elevated antipseudomonal antibody concentrations were also found in serum from the patients free of P.a. infection -for AP and ELA antigens -in 7% of patients for each antigen, for Exo-A -in 15% of patients, and for at least one antigen -in 5 patients (19%) ( Table 2) . Normal antibodies concentration (< 500 U) was found in 50 patients: including 81% of patients free of infection to date, in 65% of patients with intermittent infection, and in 18% of chronically infected patients. Table 3 presents the absolute values of antipseudomonal antibodies depending on infection chronicity. Significantly higher concentrations of the examined antibodies were observed in chronically infected patients in comparison to other groups (p < 0.001).
In 57 patients with currently P.a.-positive culture, elevated levels of antibodies to AP, ELA and Exo-A antigens were found in 91%, 87% and 85% of patients, respectively. Table 4 shows antipseudomonal antibody concentrations depending on the current growth of P.a. from sputum. Significantly higher antibodies concentrations were found in the case of the current growth of mucoid type of P. aeruginosa, compared to the non-mucoid type of P.a. 
Discussion
In the presented group of children and young adults with cystic fibrosis, it was shown that the frequency of isolation of P. aeruginosa increases together with age, in accordance with data published by other authors [4] .
Negative results of culture in 13% of chronically infected patients with P.a., and in 69% of intermittently infected patients, illustrate the difficulties concerning culturing methods in the examined population. Potential reasons include, among others, the problems with obtaining material from the lower airways, particularly in younger patients (in some of them a pharyngeal swab was collected). The other possible cause of negative culture in chronically infected patients is the growth of P. aeruginosa in the airways in the form of biofilm. In such cases the secretion includes only single colonies of P.a. that leave biofilm [5] . In the present study some patients received the therapy with an inhaled antibiotic. In such circumstances the material was taken at least 12 hours after the last dose, so it was unlikely that it influenced the obtained results, as the concentration of inhaled antibiotic in the secretion decreases rapidly below MIC [7] .
The main exoproducts of P. aeruginosa are: alginate capsule (which acts as an adhesive and antiphagocytic factor), pilin (important during initial colonisation of the epithelium), adhesins, toxins [among others lipopolysaccharide, enterotoxin, exotoxin S (exoenzyme S), exotoxin A -the main toxin of P. aeruginosa], hemolysins (which degrade surfactant) and proteases (e.g. elastase, alkaline protease). The production of proteases that decompose fibronectin and expose receptors plays a crucial role in the invasion and favours the spread of infection. Moreover, elastase decomposes collagen, IgG, IgA and the components of the complement, whereas alkaline protease degrades fibrin. They both participate in inactivation of interferon and TNF [8] .
Immunologic response to P.a. infection results in the production of antibodies directed against antigens and toxins of the bacteria [4, 6] .
In the study groups, the increase in the prevalence and concentration of IgG antibodies to the three antigens (AP, ELA and Exo-A), with increasing chronicity of infection by P. aeruginosa, was found. The obtained results confirm the possibility of monitoring the response of the immune system to P.a. antigens by measuring the concentration of antibodies to antigens of the bacteria. The highest antibodies concentrations were found in patients infected with mucoid strain of P. aeruginosa. As mucoid strains appear mostly in patients with chronic infection, it suggests the role of time (and possibly the intensity) of stimulation with P.a. antigens in provoking immune response. Other researchers also showed that in CF patients, the response of the immune system is greater in the case of infection with mucoid phenotype of P.a. These antibodies are not able to inhibit bacteria growth, but they participate in the development of immune complexes that activate specific and non-specific inflammatory defence mechanisms of the lungs. Chronic inflammatory process is the main cause of destruction, worsening of lung function and developing progressive respiratory insufficiency [7, 9] . Therefore, it is possible that detection of specific antipseudomonal antibodies in CF may help in the identification of patients with aggressive forms of chronic infection [10] .
In the study group, antipseudomonal antibodies concentration was highest in chronically infected patients. However, in 18% of chronically infected patients, elevated antibody concentration was not found. The clinical meaning of this finding was unclear, but the possible reasons could be corticotherapy in some patients, low sensitivity of serological test or the lack of current P. aeruginosa growth from sputum.
In the present study, in 19% of patients, increased concentration of antibodies for at least one P. aeruginosa antigen was found -in spite of permanently negative results of cultures. This finding might be caused by latent or intermittent P.a. infection and requires further clinical observation, in particular, repeated cultures of material from the airways.
It should be emphasised that current indications for P. aeruginosa eradication depend on microbiological confirmation of the presence of bacteria in the airways. According to current knowledge, treatment based only on antibody concentration cannot be recommended, but it may be an indication for more intensive microbiological testing (e.g. verification through culturing the material obtained from bronchoscopy) [10] [11] [12] .
West et al. found that in CF patients diagnosed through screening tests of newborn infants, P. aeruginosa infection of the lungs had occurred between the 6 th and 12 th months [13] . Monitoring the titre of anti P.a. antibodies could perhaps facilitate recognition and treatment of P.a. infections in such population.
Serological diagnosis of P.a. infection in CF has been applied in clinical practice in Europe for www.pneumonologia.viamedica.pl many years. In the USA and Canada it is used for scientific purposes only [14] . Lowering of antibody titre in response to treatment with tobramycin inhalations in patients with early P.a. infection has been shown, but in patients with chronic P.a. infection the level of antibodies rarely decreased in response to antibacterial treatment.
The results of the present study are in accordance with data of Kappler et al. [1] , who used the same commercialised sets to determine the three serum IgG antibodies against P. aeruginosa (AP, ELA and Exo-A). Positive antibody titre was indicative for the presence of P. aeruginosa in the airways with a sensitivity of 86% and specificity of 90%, whereas a negative result indicated lack of P. aeruginosa infection with a positive predictive value of 97%, (especially in younger children). From a clinical perspective, regular determination of the serum level of antibodies to P.a. may be useful in patients with negative microbiological P. aeruginosa status. If the antibody titre rises, P. aeruginosa infection is suspected, which should lead to intensive microbiological testing and a possible eradication treatment.
The obtained results imply that periodic serum antibody determination may be useful in CF patients who were to date free of P. aeruginosa infection, or who were infected intermittently.
Conclusions
In the study group of patients with cystic fibrosis, immune response to infection with P. aeruginosa in the majority of cases depended on the time and intensity of infection. In the patients with chronic P.a. infection, higher antibody concentration was found, in comparison with intermittently infected patients.
Anti P.a. antibody concentration was also dependent of the current presence of P. aeruginosa strain in the culture and its type -the highest values were observed in patients currently infected with mucoid type of P.a.
Elevated antibody concentration for at least one out of three P. aeruginosa antigens was also found in 19% of patients free of the pathogen.
It may imply latent P.a. infection in this group of patients and needs further investigation and correlation with clinical data.
Low concentrations of antibodies against P. aeruginosa that were found in 18% of patients chronically infected with P.a. is an interesting finding, the interpretation of which is possible only in the context of the clinical course of the disease.
